![BE](/sites/all/themes/wivisp/images/be_logo_color.png)
- Bedoelde u
- barbara, c
Zoekresultaten - 20 results
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021
Patricia CJL; Gomez, Verónica; Lesieur, Zineb; Barbezange, Cyril; van Nedervelde, Els; Borg, Maria-Louise; Castilla, Jesús; Lazar, Mihaela; O’Donnell, Joan; Jonikaite, Indrė; Demlová, Regina; Amerali, ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022
Lovrić Makarić, Zvjezdana; Cauchi, John Paul; Barbezange, Cyril; van Nedervelde, Els; O’Donnell, Joan; Durier, Christine; Guiomar, Raquel; Castilla, Jesús; Jonikaite, Indrė; Bruijning-Verhagen, Patricia ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Lovrić Makarić, Zvjezdana; Cauchi, John Paul; Barbezange, Cyril; van Nedervelde, Els; O'Donnell, Joan; Durier, Christine; Guiomar, Raquel; Castilla, Jesús; Jonikaite, Indrė; Bruijning-Verhagen, ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Patricia CJL; Gomez, Verónica; Lesieur, Zineb; Barbezange, Cyril; van Nedervelde, Els; Borg, Maria-Louise; Castilla, Jesús; Lazar, Mihaela; O'Donnell, Joan; Jonikaite, Indrė; Demlová, Regina; Amerali, ...
Genomic monitoring of SARS-CoV-2 variants using sentinel SARI hospital surveillance.
Baele, Guy; Dellicour, Simon; Cuypers, Lize; André, Emmanuel; Couvreur, Simon; Brondeel, Ruben; Cyril Barbezange *; Bossuyt, Nathalie; Steven Van Gucht Source: Influenza Other Respir Viruses, Volume 17, ...
Risk Factors Associated with Severe RSV Infection in Infants: What Is the Role of Viral Co-Infections?
Publication Type: Peer reviewed scientific article Authors: Stobbelaar, Kim; Mangodt, Thomas C; Van der Gucht, Winke; Delhaise, Lise; Andries, Jasmine; Gille, Valérie; Barbezange, Cyril; Smet, ...
Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort studyObjectivesDesignSettingParticipantsOutcome measuresResultsConclusionsTrial registration number
Publication Type: Peer reviewed scientific article Authors: Laure Mortgat; Kristien Verdonck; Veronik Hutse; Isabelle Thomas; Cyril Barbezange; Heyndrickx, Leo; Nathalie Fischer; Vuylsteke, Bea; ...
Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023.
Publication Type: Peer reviewed scientific article Authors: Kissling, Esther; Maurel, Marine; Emborg, Hanne-Dorthe; Whitaker, Heather; McMenamin, Jim; Howard, Jennifer; Trebbien, Ramona; Watson, Conall; Findlay, Beth; Pozo, Francisco; Bolt Botnen, Amanda; ...
Genomic monitoring of SARS‐CoV‐2 variants using sentinel SARI hospital surveillance
Dellicour, Simon; Cuypers, Lize; André, Emmanuel; Simon Couvreur; Ruben Brondeel; Cyril Barbezange; Nathalie Bossuyt; Steven Van Gucht Source: Influenza and Other Respiratory Viruses, Volume 17, Issue 10 ...
Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial.
Publication Type: Peer reviewed scientific article Authors: Els Tobback; Sophie Degroote; Sabine Buysse; Liesbeth Delesie; Lucas Van Dooren; Sophie Vanherrewege; Cyril Barbezange; Veronik Hutse; ...